gsgs
Registered User
http://www.blackwell-synergy.com/toc/irv/2/2
7 issues so far:
--------------------------------------------
Reference viruses for seasonal and pandemic influenza vaccine preparation
Avian influenza infections in birds ? a moving target
A launch vector for the production of vaccine antigens in plants
Antivirals for the treatment and prevention of epidemic and pandemic influenza
Production of a novel influenza vaccine using insect cells: protection against drifted strains
--------------------------------------------
Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning
Vaccines for an influenza pandemic: scientific and political challenges
Rationale for treating human influenza infections by passive transfer of specific antibodies
Avian influenza and poultry workers, Peru, 2006
Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1
--------------------------------------------
isirv goes formal: first AGM, first substantive Board
Options for the Control of Influenza VI Conference summary
Maximizing power in seroepidemiological studies through the use of the proportional odds model
Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies
Bioaerosol sampling for the detection of aerosolized influenza virus
Oligonucleotide microchip for subtyping of influenza A virus
---------------------------------------------------
Expert consultation on diagnosis of H5N1 avian influenza infections in humans
Writing team for The Global Influenza Programme*
Local and systemic cytokine and chemokine responses after parenteral influenza vaccination
Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination
Generation of candidate human influenza vaccine strains in cell culture ? rehearsing the European response to an H7N1 pandemic threat
Real-time RT-PCR assays for type and subtype detection of influenza A and B viruses
-------------------------------------------------------
Influenza-associated hospitalization in urban Thai children
Chest CT findings of influenza virus-associated pneumonia in 12 adult patients
Chloroquine is effective against influenza A virus in vitro but not in vivo
Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military training
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
Avian influenza A (H5N1) infection in a patient in China, 2006
Influenza vaccination coverage rates in Europe ? covering five consecutive seasons (2001?2006) in five countries
------------------------------------------------------
Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals
Non-random reassortment in human influenza A viruses
The Influenza Primer Design Resource: a new tool for translating influenza sequence data into effective diagnostics
A plant-produced influenza subunit vaccine protects ferrets against virus challenge
----------------------------------------------------
Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch
Evidence for avian influenza A infections among Iowa?s agricultural workers
Willingness to volunteer during an influenza pandemic: perspectives from students and staff at a large Canadian university
-------------------------------------------------
------------------------------------------------
Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine
7 issues so far:
--------------------------------------------
Reference viruses for seasonal and pandemic influenza vaccine preparation
Avian influenza infections in birds ? a moving target
A launch vector for the production of vaccine antigens in plants
Antivirals for the treatment and prevention of epidemic and pandemic influenza
Production of a novel influenza vaccine using insect cells: protection against drifted strains
--------------------------------------------
Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning
Vaccines for an influenza pandemic: scientific and political challenges
Rationale for treating human influenza infections by passive transfer of specific antibodies
Avian influenza and poultry workers, Peru, 2006
Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1
--------------------------------------------
isirv goes formal: first AGM, first substantive Board
Options for the Control of Influenza VI Conference summary
Maximizing power in seroepidemiological studies through the use of the proportional odds model
Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies
Bioaerosol sampling for the detection of aerosolized influenza virus
Oligonucleotide microchip for subtyping of influenza A virus
---------------------------------------------------
Expert consultation on diagnosis of H5N1 avian influenza infections in humans
Writing team for The Global Influenza Programme*
Local and systemic cytokine and chemokine responses after parenteral influenza vaccination
Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination
Generation of candidate human influenza vaccine strains in cell culture ? rehearsing the European response to an H7N1 pandemic threat
Real-time RT-PCR assays for type and subtype detection of influenza A and B viruses
-------------------------------------------------------
Influenza-associated hospitalization in urban Thai children
Chest CT findings of influenza virus-associated pneumonia in 12 adult patients
Chloroquine is effective against influenza A virus in vitro but not in vivo
Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military training
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
Avian influenza A (H5N1) infection in a patient in China, 2006
Influenza vaccination coverage rates in Europe ? covering five consecutive seasons (2001?2006) in five countries
------------------------------------------------------
Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals
Non-random reassortment in human influenza A viruses
The Influenza Primer Design Resource: a new tool for translating influenza sequence data into effective diagnostics
A plant-produced influenza subunit vaccine protects ferrets against virus challenge
----------------------------------------------------
Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs
Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch
Evidence for avian influenza A infections among Iowa?s agricultural workers
Willingness to volunteer during an influenza pandemic: perspectives from students and staff at a large Canadian university
-------------------------------------------------
------------------------------------------------
Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine